A transgenic mouse model of neuroepithelial cell specific inducible overexpression of dopamine D1-receptor.
Dopamine and its receptors appear in the brain during early embryonic period suggesting a role for dopamine in brain development. In fact, dopamine receptor imbalance resulting from impaired physiological balance between D1- and D2-receptor activities can perturb brain development and lead to persisting changes in brain structure and function. Dopamine receptor imbalance can be produced experimentally using pharmacological or genetic methods. Pharmacological methods tend to activate or antagonize the receptors in all cell types. In the traditional gene knockout models the receptor imbalance occurs during development and also at maturity. Therefore, assaying the effects of dopamine imbalance on specific cell types (e.g. precursor versus postmitotic cells) or at specific periods of brain development (e.g. pre- or postnatal periods) is not feasible in these models. We describe a novel transgenic mouse model based on the tetracycline dependent inducible gene expression system in which dopamine D1-receptor transgene expression is induced selectively in neuroepithelial cells of the embryonic brain at experimenter-chosen intervals of brain development. In this model, doxycycline-induced expression of the transgene causes significant overexpression of the D1-receptor and significant reductions in the incorporation of the S-phase marker bromodeoxyuridine into neuroepithelial cells of the basal and dorsal telencephalon indicating marked effects on telencephalic neurogenesis. The D1-receptor overexpression occurs at higher levels in the medial ganglionic eminence (MGE) than the lateral ganglionic eminence (LGE) or cerebral wall (CW). Moreover, although the transgene is induced selectively in the neuroepithelium, D1-receptor protein overexpression appears to persist in postmitotic cells. The mouse model can be modified for neuroepithelial cell-specific inducible expression of other transgenes or induction of the D1-receptor transgene in other cells in specific brain regions by crossbreeding the mice with transgenic mouse lines available already.
Fujimoto
K
K
Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.
Araki
K
K
McCarthy
D M
DM
Sims
J R
JR
Ren
J Q
JQ
Zhang
X
X
Bhide
P G
PG
D000818:Animals; D001921:Brain / Q000196:embryology* / Q000254:growth & development / Q000378:metabolism; D004318:Doxycycline / Q000494:pharmacology; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D018014:Gene Transfer Techniques; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D046569:Neuroepithelial Cells / Q000378:metabolism*; D017447:Receptors, Dopamine D1 / Q000096:biosynthesis*; D015854:Up-Regulation / Q000187:drug effects*
D017447:Receptors, Dopamine D1; D004318:Doxycycline